Log in to save to my catalogue

Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern...

Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9334538

Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron

About this item

Full title

Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron

Publisher

Singapore: Springer Nature Singapore

Journal title

Cell research, 2022-09, Vol.32 (9), p.831-842

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

SARS-CoV-2 variants with adaptive mutations have continued to emerge, causing fresh waves of infection even amongst vaccinated population. The development of broad-spectrum antivirals is thus urgently needed. We previously developed two hetero-bivalent nanobodies (Nbs), aRBD-2-5 and aRBD-2-7, with potent neutralization activity against the wild-typ...

Alternative Titles

Full title

Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9334538

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9334538

Other Identifiers

ISSN

1748-7838,1001-0602

E-ISSN

1748-7838

DOI

10.1038/s41422-022-00700-3

How to access this item